Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001283981 | SCV001160033 | uncertain significance | not provided | 2022-11-17 | criteria provided, single submitter | clinical testing | The Hb Hopkins-II variant (HBA1 c.337C>G; p.His113Asp, also known as His112Asp when numbered from the mature protein, rs34830032, HbVar ID: 173) is reported in the literature without clinical information (see HbVar link and references therein). This variant is reported in ClinVar (Variation ID: 15745), and is only observed on one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. The histidine at codon 113 is highly conserved, and computational are uncertain whether this variant is neutral or deleterious (REVEL: 0.535). Due to limited information, the clinical significance of the Hb Hopkins-II variant is uncertain at this time. References: Link to HbVar: https://globin.bx.psu.edu/hbvar/hbvar.html |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001283981 | SCV001469514 | uncertain significance | not provided | 2020-02-20 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000017050 | SCV000037322 | other | HEMOGLOBIN HOPKINS 2 | 2016-07-20 | no assertion criteria provided | literature only | |
Natera, |
RCV001826475 | SCV002093863 | uncertain significance | alpha Thalassemia | 2021-02-05 | no assertion criteria provided | clinical testing |